Endovascular treatment of an Axillary Artery Pseudoaneurysm after Anterior Shoulder Dislocation: A Case Report
Abstract
Traumatic injury of the axillary artery after shoulder dislocation is a rare event. Till recently, surgical repair was the only viable option in this type of pathology, with high morbidity and even mortality rates reported. In recent years, endovascular interventions became an effective method to treat arterial pathology including blunt arterial injuries. We present a case of an 82-year old man with a traumatic pseudoaneurysm of the right axillary artery after anterior shoulder dislocation. The patient was successfully treated by stent graft placement over the arterial tear. Despite the technical success, serious neurological impairment persisted after the procedure.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
